###begin article-title 0
Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells
###end article-title 0
###begin p 1
###xml 875 878 <span type="species:ncbi:10116">rat</span>
Carnitine palmitoyltransferase 1 (CPT1) catalyzes the first step in long-chain fatty acid import into mitochondria, and it is believed to be rate limiting for beta-oxidation of fatty acids. However, in muscle, other proteins may collaborate with CPT1. Fatty acid translocase/CD36 (FAT/CD36) may interact with CPT1 and contribute to fatty acid import into mitochondria in muscle. Here, we demonstrate that another membrane-bound fatty acid binding protein, fatty acid transport protein 1 (FATP1), collaborates with CPT1 for fatty acid import into mitochondria. Overexpression of FATP1 using adenovirus in L6E9 myotubes increased both fatty acid oxidation and palmitate esterification into triacylglycerides. Moreover, immunocytochemistry assays in transfected L6E9 myotubes showed that FATP1 was present in mitochondria and coimmunoprecipitated with CPT1 in L6E9 myotubes and rat skeletal muscle in vivo. The cooverexpression of FATP1 and CPT1 also enhanced mitochondrial fatty acid oxidation, similar to the cooverexpression of FAT/CD36 and CPT1. However, etomoxir, an irreversible inhibitor of CPT1, blocked all these effects. These data reveal that FATP1, like FAT/CD36, is associated with mitochondria and has a role in mitochondrial oxidation of fatty acids.
###end p 1
###begin p 2
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 687 688 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
Fatty acids are a major energy source for skeletal muscle. They are transported into the cell via a protein-mediated mechanism, involving fatty acid translocase/CD36 (FAT/CD36), plasma-membrane-associated fatty acid binding protein, and fatty acid transport protein (FATP1-6) (1). Once inside the cell, fatty acids can be esterified, metabolized to lipid second messengers, such as leukotrienes and eicosanoids, or beta-oxidized in the mitochondrion. The first step of the oxidative pathway is the transport of fatty acids into the mitochondrial matrix. This step is controlled by the carnitine palmitoyltransferase (CPT) system, consisting of CPT1, acylcarnitine translocase, and CPT2 (2).
###end p 2
###begin p 3
###xml 97 98 97 98 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 443 444 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 549 550 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 551 552 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
CPT1 catalyzes the conversion of long-chain fatty acyl-CoAs to acylcarnitines in the presence of l-carnitine and is the rate-limiting step in the transport of long-chain fatty acids (LCFAs) from the cytoplasm to the mitochondrial matrix, where they undergo beta-oxidation. CPT1 is tightly regulated by its physiological inhibitor malonyl-CoA. This regulation allows CPT1 to signal the availability of lipid and carbohydrate fuels to the cell (2). Mammalian tissues express three isoforms: CPT1A (liver), CPT1B (muscle and heart), and CPT1C (brain) (3-5).
###end p 3
###begin p 4
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 535 536 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 538 540 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 596 598 592 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1180 1182 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 1437 1439 1417 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
Owing to the metabolic peculiarities of muscle, the regulation of CPT1B by malonyl-CoA is more complex than that of CPT1A in liver. The regulation of muscle CPT1 by malonyl-CoA cannot fully explain changes in mitochondrial fatty acid import. Thus, malonyl-CoA is not responsible for the increase in fatty acid oxidation during the transition from low to moderate aerobic exercise or for the decrease in fatty acid oxidation during more strenuous exercise (6-8). Moreover, concentrations of malonyl-CoA measured in muscle (1-4 microM) (9, 10) should inhibit CPT1 activity at any time, since the IC50 of CPT1B for malonyl-CoA is much lower than this concentration (approximately0.03 microM). Several hypotheses have been advanced to explain this discordance between malonyl-CoA levels, CPT1 regulation, and LCFA oxidation in muscle. Thus, alteration in compartmentalization/cellular distribution of malonyl-CoA may be involved in the control of CPT1 activity. It has been proposed that the malonyl-CoA involved in CPT1 regulation is that synthesized by acetyl-CoA carboxylase 2, which resides in the vicinity of CPT1 in the outer mitochondrial membrane and modulates CPT1 activity (11). Moreover, other proteins could also be involved in the transport of fatty acids into mitochondria. Thus, Bonen and coworkers demonstrated that exercise induces the translocation of FAT/CD36 to mitochondria, thus increasing muscle fatty acid oxidation (12).
###end p 4
###begin p 5
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 1306 1308 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 1310 1312 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 655 670 <span type="species:ncbi:10090">transgenic mice</span>
###xml 895 900 <span type="species:ncbi:9606">human</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
FATPs are a family of membrane-bound proteins that catalyze the ATP-dependent esterification of LCFA and very-LCFA to their acyl-CoA derivatives (13-15). Mammals express six different forms of FATP (FATP1-6) with tissue-specific expression patterns (14). FATP1 is a 63 kDa protein that is expressed in cells and tissues with high levels of fatty acid uptake for metabolism or storage, such as skeletal muscle and adipose tissue (15). The regulatory role of FATP1 in metabolism has been partially elucidated by gene manipulation. Overexpression of FATP1 in cultured fibroblasts increases fatty acid uptake (16). Cardiac-specific overexpression of FATP1 in transgenic mice increases myocardial fatty acid uptake and free FA accumulation, but not triacylglyceride (TG) levels, and enhances palmitate oxidation leading to a lipotoxic cardiomyopathy (17). In contrast, when overexpressed in cultured human skeletal myotubes, FATP1 stimulates FA uptake and storage as TG, but not oxidation (18). Deletion of FATP1 protects mice from fatty-acid-induced insulin resistance and intramuscular accumulation of fatty acyl-CoAs (19). Furthermore, FATP1 is involved in hormonal regulation of fatty acid uptake, translocating to the plasma membrane in response to insulin in adipocytes and primary skeletal muscle cells (20, 21).
###end p 5
###begin p 6
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
We have recently shown that overexpression of CPT1A in L6E9 myotubes enhanced CPT1 activity up to 15-fold, whereas fatty acid oxidation did not increase more than 2-fold, even when a mutant form of CPT1 insensitive to malonyl-CoA was overexpressed (22). These data indicate that other factors independent of CPT1/malonyl-CoA interaction could be involved in the control of fatty acid oxidation in these cells. In the search for a novel regulator of fatty acid oxidation in skeletal muscle, we examined the effect of FATP1 overexpression on fatty acid oxidation in L6E9 muscle cells. We show that FATP1 localized in mitochondria and coimmunoprecipitated with CPT1. Moreover, FATP1 overexpression enhanced mitochondrial oxidation of fatty acids. We also observed all these effects in cells overexpressing FAT/CD36, which may have a role in this process in muscle (12). These data reveal a new protein involved in beta-oxidation and could help us to understand its complex regulation in skeletal muscle.
###end p 6
###begin title 7
EXPERIMENTAL PROCEDURES
###end title 7
###begin title 8
Materials and reagents
###end title 8
###begin p 9
###xml 439 441 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 464 466 462 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 532 538 <span type="species:ncbi:9986">rabbit</span>
###xml 576 582 <span type="species:ncbi:9986">rabbit</span>
Protran(R) nitrocellulose membranes for protein analysis were from Scheicher and Schuell (Keene, NH). The enhanced chemifluorescence detection kit from Amersham Biosciences was used for Western blot analysis. The Bradford solution for protein assay was from Bio-Rad Laboratories (Hercules, CA). FBS, DMEM, and antibiotics were from Gibco-Invitrogen. Defatted BSA (BSA), palmitate, and other chemicals were purchased from Sigma-Aldrich. [1-14C]Palmitic acid and [1-14C]palmitoyl-CoA were from GE Healthcare. Antibodies used included rabbit polyclonal anti-FATP1 (sc-14497) and rabbit polyclonal anti-FAT/CD36 (sc-9154) from Santa Cruz Biotechnologies, anti-green fluorescent protein (GFP) (ref. 8360-1) from Clontech, anti-COI of complex IV from Molecular Probes, and anti-porin from Calbiochem. Silica gel 60 TLC plates were from Merck (Rahway, NJ). Etomoxir was provided by H. P. O. Wolf (GMBH, Allensbach, Germany).
###end p 9
###begin title 10
Animals
###end title 10
###begin p 11
###xml 64 83 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Samples of gastrocnemius and soleus muscle were taken from male Sprague-Dawley rats (180-200 g) bred in our laboratory. Animals were maintained under a 12 h dark/light cycle at 23degreesC with free access to food and water. All experimental protocols were approved by the Animal Ethics Committee at the University of Barcelona.
###end p 11
###begin title 12
Cell culture
###end title 12
###begin p 13
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 9 12 <span type="species:ncbi:10116">rat</span>
The L6E9 rat skeletal muscle cell line was cultured in a humidified atmosphere containing 5% CO2 in DMEM medium containing 10% FBS, 100 units/ml penicillin G, and 100 mug/ml streptomycin and 25 mmol/l HEPES (pH 7.4) (growth medium). Preconfluent myoblasts (80-90%) were induced to differentiate by lowering FBS to a final concentration of 2% (v/v) (differentiation medium). Cells were completely differentiated after 4 days in this medium.
###end p 13
###begin title 14
Adenoviral preparation and transduction of L6E9 cells
###end title 14
###begin p 15
###xml 196 198 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 200 202 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 343 345 340 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 453 454 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 481 483 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 511 513 508 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 548 550 545 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 18 21 <span type="species:ncbi:10116">rat</span>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 81 84 <span type="species:ncbi:10116">rat</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
Ad-CPT1A encoding rat CPT1A, Ad-FATP1 encoding mouse FATP1, Ad-FAT/CD36 encoding rat FAT/CD36, and Ad-LacZ, which expresses bacterial beta-galactosidase, were constructed as previously described (18, 23). Adenoviruses were amplified using the human embryonic kidney cell line (HEK 293) as host. Lysates obtained were titrated using the Adeno-XTM Rapid Titer kit (Clontech) and used directly for cell transduction. The titers of the lysates were 2.3 x 109 pfu/ml for Ad-LacZ, 1 x 1010 pfu/ml for Ad-CPT1A, 1 x 1010 pfu/ml for Ad-FAT/CD36, and 3 x 1010 pfu/ml for Ad-FATP1. Myotubes were transduced at day 4 of differentiation with 20 pfu/cell of Ad-LacZ, Ad-FATP1, or Ad-CPT1A and 5 pfu/cell of Ad-FAT/CD36 in serum-free medium for 30 h. After this time, the infection medium was removed and cells were incubated with serum-free medium for a further 16 h.
###end p 15
###begin title 16
Transfection of L6E9 cells
###end title 16
###begin p 17
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
The plasmids pFATP1-GFP and pFAT/CD36-GFP, which include an NH2-terminal fusion protein construct with the GFP (20), were transfected in L6E9 myoblasts using FuGENE 6 (Roche) following the manufacturer's guidelines. After transfection, cells were differentiated and used for the experiments.
###end p 17
###begin title 18
Measurement of fatty acid oxidation in intact cells
###end title 18
###begin p 19
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 373 374 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 377 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 404 405 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 417 418 417 418 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 709 711 696 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 808 809 795 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Palmitate oxidation to CO2 and acid-soluble products (ASPs), essentially acyl-carnitine, Krebs cycle intermediates, and acetyl-CoA (24), were measured in L6E9 cells grown in 6-well plates, differentiated, and transduced as described above. On the day of the assay, cells were washed in Krebs-Ringer bicarbonate HEPES buffer (KRBH buffer: 135 mM NaCl, 3.6 mM KCl, 0.5 mM NaH2PO4, 0.5 mM MgSO4, 1.5 mM CaCl2, 2 mM NaHCO3, and 10 mM HEPES, pH 7.4) that contained 0.1% BSA, preincubated at 37degreesC for 30 min in KRBH 1% BSA and washed again in KRBH 0.1% BSA. Cells were then incubated for 3 h at 37degreesC with fresh KRBH containing 2.5 mM glucose and 0.8 mM carnitine plus 0.25 mM palmitate and 1 muCi/ml [1-14C]palmitate bound to 1% BSA. Oxidation measurements were performed by trapping the radioactive CO2 in a parafilm-sealed system. The reaction was stopped by the addition of 40% perchloric acid through a syringe that pierced the parafilm.
###end p 19
###begin title 20
###xml 46 49 <span type="species:ncbi:10116">rat</span>
Isolation of mitochondria from L6E9 cells and rat skeletal muscle
###end title 20
###begin p 21
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 314 315 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 569 570 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Mitochondria-enriched cell fractions from L6E9 myotubes were obtained as previously described (23) with some modifications. Briefly, L6E9 cells were grown in 150 mm dishes, left to differentiate, and transduced as described above. Cells were scraped out and resuspended in 1 ml of solution A (100 mM KCl, 5 mM MgSO4, 5 mM EDTA, 1 mM ATP, and 50 mM Tris-HCl, pH 7.4). Cells were homogenized using a glass homogenizer (20 strokes with both the loose and the tight pestle) and centrifuged at 2,000 g for 3 min at 4degreesC. The supernatant was centrifuged again at 16,000 g for 30 min at 4degreesC. The mitochondria-enriched pellet was resuspended in 50-100 microl of solution B (220 mM sucrose, 70 mM mannitol, 1 mM EDTA, and 10 mM Tris-HCl, pH 7.4) and used for immunoprecipitation or palmitate oxidation assays. The quality of mitochondria was assessed measuring the malonyl-CoA-resistant CPT1 activity, attributable basically to CPT2 activity inside the mitochondrion, allowing us to quantify broken mitochondria. According to this method, the integrity of mitochondria was higher than 80% (data not shown).
###end p 21
###begin p 22
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Mitochondria-enriched fractions from rat muscle were obtained by differential centrifugation. Two soleus muscle samples or one gastrocnemius muscle sample from each animal were homogenized separately in 9 volumes of solution A using an omnimixer and then centrifuged at 1,000 g for 15 min. The pellet was homogenized and centrifuged at 600 g for 10 min. The resulting supernatant was centrifuged at 15,000 g for 15 min, and the pellet was washed twice in solution A and resuspended at 1 microl/mg tissue in solution B.
###end p 22
###begin title 23
Measurement of palmitate and palmitoyl-CoA oxidation in isolated mitochondria
###end title 23
###begin p 24
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 410 412 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 484 486 464 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 597 598 567 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 604 605 574 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 684 685 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 687 688 657 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 701 702 671 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 765 766 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 775 776 745 746 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1020 1022 973 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1138 1140 1087 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 1314 1315 1259 1260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
L6E9 cells were cultured in 150 mm dishes, differentiated, and transduced as described above. Mitochondria-enriched fractions were obtained and resuspended in solution B. Fatty acid oxidation was measured as described elsewhere (12) with minor modifications. For palmitate oxidation assays, 50 microl (150 microg) of mitochondria and 50 microl of a 2.5 mM 5:1 palmitate-BSA complex containing 10 microCi/ml [1-14C]palmitate (final concentration: 0.25 mM palmitate and 1 microCi/ml [1-14C]palmitate) were incubated for 1 h with agitation in 400 microl of pregassed (37degreesC for 15 min with 5% CO2-95% O2) modified Krebs Ringer HEPES (MKRH) buffer (115 mM NaCl, 2.6 mM KCl, 1.2 mM KH2PO4, 10 mM NaHCO3, and 10 mM HEPES, pH 7.4) supplemented with 5 mM ATP, 1 mM NAD+, 0.5 mM l-carnitine, 0.1 mM CoA, 0.5 mM malate, and 25 muM cytochrome C (complete MKRH buffer). For palmitoyl-CoA oxidation assays 50 microl (400 microg) of mitochondria and 50 microl of a 2.5 mM 5:1 palmitoyl-CoA-BSA complex containing 1 microCi/ml [1-14C]palmitoyl-CoA was added to the reaction mixture (final concentration: 0.25 mM palmitoyl-CoA and 0.1 microCi/ml [1-14C]palmitoyl-CoA) were incubated for 0.5 h with agitation in 400 microl of pregassed complete MKRH buffer. Oxidation measurements were performed by trapping the radioactive CO2 and ASPs in a parafilm-sealed system in a 6-well plate with agitation. The reaction was stopped by the addition of 40% perchloric acid through a syringe that pierced the parafilm.
###end p 24
###begin title 25
Measurement of palmitate incorporation into cellular lipids
###end title 25
###begin p 26
###xml 253 255 246 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 385 387 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 628 630 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
Palmitate incorporation into complex lipids was measured in L6E9 cells that were cultured on 6-well plates and pretreated as described above. Cells were incubated for 16 h at 37degreesC in serum-free medium containing 0.25 mM palmitate and 1 muCi/ml [1-14C]palmitate bound to 1% BSA. On the day of the assay cells were washed in PBS, and lipids were extracted as described previously (23). Total lipids were dissolved in 30 mul of chloroform and separated by TLC to measure the incorporation of labeled fatty acid into phospholipids (PLs), diacylglycerol (DAG), TGs, and nonesterified labeled palmitate (NE palm), as described (22).
###end p 26
###begin title 27
Measurement of acyl-CoA synthetase activity
###end title 27
###begin p 28
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 227 229 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 279 280 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 620 621 586 587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 623 624 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Samples were assayed for acyl-CoA synthetase activity by the conversion of [1-14C]palmitate to its CoA derivative (13). The assay mixture contained, in a total volume of 200 microl: 100 mM Tris-HCl buffer, pH 7.5, 50 microM [1-14C]palmitate (0.2 microCi/ml), 10 mM ATP, 5 mM MgCl2, 200 microM CoA, 200 microM DTT, and 0.4% Triton X-100. The assay was initiated by addition of 5-10 microl of enzyme suspension (30-50 microg) from total or mitochondrial extracts from L6E9 myotubes. The reaction was carried out at 30degreesC for 5 min. Reactions were terminated with the addition of 1.25 ml of isopropyl alcohol:heptane:H2SO4 (40:10:1, v/v/v), 0.5 ml of water, and 0.75 ml of heptane to facilitate organic phase separation. The aqueous phase was extracted three times with 0.75 ml of heptane to remove unreacted fatty acids, and the radioactivity was determined by liquid phase scintillation counting.
###end p 28
###begin title 29
Immunoprecipitation
###end title 29
###begin p 30
###xml 439 440 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 726 727 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1383 1385 1358 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 1568 1570 1543 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 64 67 <span type="species:ncbi:10116">rat</span>
###xml 1372 1375 <span type="species:ncbi:10116">rat</span>
###xml 1557 1560 <span type="species:ncbi:10116">rat</span>
###xml 1662 1665 <span type="species:ncbi:10116">rat</span>
Immunoprecipitation studies were performed in L6E9 myotubes and rat skeletal muscle. L6E9 cells were grown on 150 mm plates, differentiated, and transduced with the adenoviruses. After transduction, cells were collected in PBS and homogenized with a douncer in 500 mul of lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM EGTA, 1 muM PMSF, 25 mug/ml leupeptin, and 25 mug/ml aprotinin) and centrifuged at 700 g for 10 min to remove nuclei, cell debris, and floating cells. For muscle studies, two soleus samples or one gastrocnemius sample were homogenized in 9 volumes of lysis buffer using a polytron. Homogenates were rotated for 1 h at 4degreesC in an orbital shaker and centrifuged at 5,000 g for 10 min at 4degreesC. After that, 1,000 or 2,000 mug of protein was immunoprecipitated with 5 mug/ml of either anti-FATP1 or anti-FAT/CD36 antibody. For immunoprecipitation studies in mitochondria, mitochondrial fractions were obtained as described above, 1% Triton X-100 was added to each preparation, and 150 or 300 mug of each fraction was used. Immunoprecipitates were collected on protein A-Sepharose G beads, washed five times in lysis buffer, resuspended, and incubated for 5 min at 95degreesC in 1x SDS-PAGE sample buffer. Samples were resolved in 8% SDS-PAGE. A CPT1A-specific polyclonal antibody against amino acids 317-430 of the rat CPT1A (25) (1/6,000 dilution) was used for the detection of CPT1A protein in the immunoprecipitates from L6E9 myotubes. A CPT1B-specific antibody against amino acids 259-760 of the rat CPT1B (26) was used (1/1,000 dilution) for detection of CPT1B protein in the immunoprecipitates from rat skeletal muscle.
###end p 30
###begin title 31
Immunofluorescence
###end title 31
###begin p 32
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 388 392 <span type="species:ncbi:9925">goat</span>
###xml 567 571 <span type="species:ncbi:9925">goat</span>
Cells grown on cover slips were fixed for 15 min with 3% paraformaldehyde in PBS and then rinsed three times with PBS and subsequently incubated for 10 min in PBS containing 50 mM NH4Cl, for 10 min with PBS containing 20 mM glycine, and for 10 min in PBS containing 0.1% triton X-100 and 0.05% colic acid. Cells were then washed three times in PBS 1x and for 30 min in PBS containing 10% goat serum. Thereafter, cover slips were incubated with primary antibodies at 0.5-1.0 microg/ml anti-COI of complex IV (Molecular Probes) and revealed with fluorochrom-conjugated goat secondary antibodies (Texas Red). Cells were rinsed three times with PBS prior to mounting in medium for fluorescence microscopy (Vectashield). Fluorescence images were obtained with a Leica TCS 4D confocal scanning laser microscope adapted to an inverted Leitz DMIRBE microscope and 63x (numerical aperture 1.4 oil) Leitz Plan-Apo objectives. The light source was an argon/krypton laser (75 mW), with which optical sections (0.1 microm) were obtained. Qualitative analyses of colocalization were assessed using the plugin RGB Profiler from the WCIF ImageJ software. A line was drawn arbitrarily over an area of interest and the plot presented the overlap of the staining of each laser (from distinct labeled proteins). Quantitative analyses were performed by calculating Pearson's correlation coefficient and Mander's overlap coefficient, which are both described in the online manual for the WCIF ImageJ collection. In many forms of correlation analysis, the value for Pearson's range from 1 to -1. A value close to 1 does indicates reliable colocalization. The Mander's overlap coefficient ranges from 1 to 0, with 1 being high colocalization and 0 being low. Having defined and eliminated the background noise from the original picture, we used the plugin Intensity Correlation Analysis from WCIF ImageJ software.
###end p 32
###begin title 33
Western blotting
###end title 33
###begin p 34
###xml 462 463 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 527 528 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 606 608 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
Mitochondrial fractions were obtained by differential centrifugation of muscle cell homogenates. Extracts were prepared by scraping L6E9 cell monolayers from 6 cm dishes into 700 microl of homogenization buffer consisting of 250 mM sucrose, 10 mM HEPES (pH 7.4), 1 mM EDTA, 1 muM PMSF, 25 mug/ml leupeptin, 25 mug/ml pepstatin A, and 25 mug/ml aprotinin. Cells were homogenized with the aid of a 22G-syringe (15 times). The homogenates were centrifuged at 1,500 g for 10 min, and the supernatant was then centrifuged at 10,000 g for 10 min to obtain a pellet enriched in mitochondria and other organelles (27). All fractions were stored at -80degreesC, and an aliquot of the cell extracts was used for the measurement of protein concentration. Fifty micrograms of protein was resolved in 10% SDS-PAGE, and immunoblotting was performed with the corresponding antibody.
###end p 34
###begin title 35
Statistical Analysis
###end title 35
###begin p 36
###xml 212 213 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are expressed as means +/- SE. The significance of differences was assessed by a one-way or two-way ANOVA followed by Newman-Keuls test for comparisons post hoc. Differences were considered significant when P < 0.05.
###end p 36
###begin title 37
RESULTS
###end title 37
###begin title 38
Effect of overexpression of FATP1 on lipid partitioning in L6E9 myotubes
###end title 38
###begin p 39
###xml 180 187 180 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 180 187 180 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1"><bold>Fig. 1A</bold></xref>
###xml 709 716 701 708 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 709 716 701 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2"><bold>Fig. 2A</bold></xref>
###xml 813 814 805 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 904 911 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2B</xref>
###xml 1075 1077 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 1143 1150 1133 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1B</xref>
###xml 1245 1252 1235 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 1302 1309 1292 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2B</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse FATP1 cDNA was delivered into L6E9 myotubes by adenovirus. FATP1 protein levels increased 2-fold in Ad-FATP1-transduced cells compared with control Ad-LacZ-transduced cells (Fig. 1A). To assess the functionality of the overexpressed FATP1, we measured the incorporation of palmitate into lipids and oxidation in intact cells. FATP1 overexpression produced a 2-fold increase in the incorporation of palmitate into TGs (LacZ control value: 0.36 +/- 0.04 nmol palmitate/mg protein x h), and no increase was seen for PLs, DAG, or nonesterified palmitate (NEPalm) (LacZ control values in nmol palmitate/mg protein x h: 0.14 +/- 0.01, 0.08 +/- 0.01, and 0.033 +/- 0.003 for PL, DAG, and NEPalm, respectively; Fig. 2A). L6E9 myotubes transduced with Ad-FATP1 showed a 1.5-fold increase in palmitate oxidation to CO2 compared with Ad-LacZ-transduced myotubes (6.5 +/- 0.27 nmol palmitate/mg protein x 3 h; Fig. 2B). We also examined the effect of FAT/CD36 overexpression in L6E9 myotubes, a protein that has already been shown to have a role in fatty acid oxidation in muscle (12). Overexpression of FAT/CD36 (2-fold increase in protein levels; Fig. 1B) produced a 1.5- to 1.8-fold increase in palmitate esterification to TG, PL, DAG, and NEPalm (Fig. 2A) and a 1.5-fold increase in palmitate oxidation (Fig. 2B).
###end p 39
###begin p 40
Overexpression of FATP1, FAT/CD36, and CPT1A in L6E9 myotubes. L6E9 myotubes were transduced with Ad-FATP1, Ad-FAT/CD36, Ad-CPT1A, or Ad-LacZ as a control, and a Western blot using a specific antibody against FATP1 (A), FAT/CD36 (B), or CPT1A (C) was performed in 50 mug of total extract.
###end p 40
###begin p 41
###xml 276 278 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 570 571 569 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 810 811 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 835 836 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effect of FATP1 overexpression on palmitate metabolism and acyl-CoA synthetase activity. A: Palmitate incorporation into complex lipids. L6E9 cells that were infected with Ad-LacZ, Ad-FATP1, and Ad-FAT/CD36 were incubated for 16 h in serum-free medium containing 1 muCi/ml [1-14C]palmitic acid and 0.25 mM unlabeled palmitate complexed to 1% (w/v) BSA. Fatty acid incorporation into TGs, DAG, PLs, and NEPalm was assessed using TLC after lipid extraction. B: Fatty acid oxidation. Cells were infected with Ad-LacZ, Ad-FATP1, or Ad-FAT/CD36, and palmitate oxidation to CO2 was measured for 3 h. C: Acyl-CoA synthetase activity was measured in both total and mitochondrial extracts coming from L6E9 myotubes transduced with Ad-LacZ or Ad-FATP1. Data are the mean SE of five experiments performed in triplicate. *P 0.01 versus Ad-LacZ; **P 0.001 versus Ad-LacZ.
###end p 41
###begin title 42
Effect of FATP1 overexpression on acyl-CoA synthetase activity
###end title 42
###begin p 43
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 583 590 579 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2C</xref>
As FATP1 has acyl-CoA synthetase activity (13), we evaluated whether the overexpression of FATP1 in L6E9 myotubes was followed by an increase in this activity. We determined the conversion of palmitate into palmitoyl-CoA in both total and mitochondria-enriched extracts. Acyl-CoA synthetase activity increased by 30% and 70% in total and mitochondrial extracts, respectively, in FATP1-overexpressing L6E9 myotubes compared with LacZ control cells (control values: 2.99 +/- 0.16 and 3.91 +/- 0.37 nmol palmitoyl-CoA/mg protein x min in total and mitochondrial extracts, respectively; Fig. 2C).
###end p 43
###begin title 44
Effect of FATP1 on fatty acid oxidation in isolated mitochondria
###end title 44
###begin p 45
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 308 315 306 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 308 315 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3"><bold>Fig. 3A</bold></xref>
###xml 469 476 467 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1C</xref>
###xml 533 535 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 609 610 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 689 690 687 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 896 897 894 895 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 939 946 937 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3A</xref>
###xml 1060 1061 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1398 1405 1394 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3B</xref>
###xml 1672 1682 1668 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3A, B</xref>
###xml 1754 1755 1750 1751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1925 1926 1921 1922 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2045 2052 2041 2048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3C</xref>
To assess the role of FATP1 in fatty acid oxidation, we measured palmitate oxidation in mitochondria-enriched fractions. Palmitate oxidation to CO2 increased 1.7-fold in mitochondria isolated from FATP1-overexpressing cells compared with Ad-LacZ infected cells (0.16 +/- 0.009 nmol palmitate/mg protein x h; Fig. 3A). As a positive control, we also evaluated palmitate oxidation in CPT1-overexpressing cells. Overexpression of CPT1A (3-fold increase in protein levels; Fig. 1C), the endogenous CPT1 isoform expressed in these cells (22), produced a 2.6-fold increase in mitochondrial palmitate oxidation to CO2. Moreover, overexpression of FAT/CD36 also increased palmitate oxidation to CO2 by 2.0-fold. To further evaluate the role of FATP1 in fatty acid oxidation, we overexpressed both FATP1 and CPT1 proteins together. The overexpression of CPT1A and FATP1 enhanced fatty acid oxidation to CO2 by 4.7-fold, showing an additive effect (Fig. 3A). Similarly, cooverexpression of CPT1A and FAT/CD36 also produced an additive effect on palmitate oxidation to CO2 (4.1-fold increase). Palmitate oxidation to ASPs, essentially consisting of acyl-carnitines, Krebs cycle intermediates, and acetyl-CoA, was increased from 1.4- to 1.8-fold in CPT1A-, FAT/CD36-, FATP1-, CPT1A+FAT/CD36-, and CPT1A+FATP1-overexpessing cells compared with Ad-LacZ control cells (36.1 +/- 1.5 nmol palmitate/mg protein x h; Fig. 3B). When mitochondria were incubated with etomoxir, an irreversible inhibitor of CPT1, the increments in fatty acid oxidation in FATP1- and FAT/CD36-overexpressing cells were blunted, confirming that CPT1 activity is necessary for fatty acid import into mitochondria (Fig. 3A, B). We also determined the ratio of incomplete (ASPs) versus complete (CO2) oxidation as a measure of mitochondrial fatty acid oxidation efficiency. The overexpression of CPT1A, FATP1, and FAT/CD36 produced a 30-40% decrease in the ratio ASP/CO2. Importantly, the cooverexpression of CPT1A together with FATP1 or FAT/CD36 produced a 50-60% decrease in this ratio (Fig. 3C), indicating that the overexpression of these proteins increased fatty acid oxidation efficiency.
###end p 45
###begin p 46
###xml 317 319 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 365 366 362 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 421 422 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 514 515 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 541 542 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 567 568 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&amp;</sup>
###xml 568 569 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 657 658 654 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 658 659 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Palmitate oxidation in mitochondrial fractions. Mitochondrial fractions that were obtained from cells infected with Ad-LacZ, Ad-FATP1, Ad-CPT1A, or Ad-FAT/CD36 were incubated for 1 h with agitation in 400 mul of pregassed complete MKRH buffer and 50 mul of a 2.5 mM 5:1 palmitate-BSA complex containing 10 muCi/ml [1-14C]palmitic acid, and palmitate oxidation to CO2 (A) and to ASPs (B) was measured. The ratio of ASPs/CO2 was also calculated (C). Data are the mean SE of five experiments performed in duplicate. *P < 0.01 versus Ad-LacZ, **P < 0.001 versus Ad-LacZ, &P < 0.001 versus the overexpression of only one protein (CPT1A, FATP1, or FAT/CD36), and #P < 0.01 versus control without etomoxir.
###end p 46
###begin p 47
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 426 427 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 579 586 577 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 579 586 577 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4"><bold>Fig. 4A</bold></xref>
###xml 785 792 781 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4B</xref>
To assess whether the role of FATP1 in the increase in mitochondrial fatty acid oxidation was due to its acyl-CoA synthetase activity, providing the substrate for CPT1, we measured palmitoyl-CoA oxidation to CO2 and ASPs in isolated mitochondria, where palmitoyl-CoA is oxidized in the absence of acyl-CoA synthetase activity. The overexpression of either CPT1 or FATP1 alone produced an increase in fatty acid oxidation to CO2 compared with LacZ control cells (2.20 +/- 0.11 nmol palmitoyl-CoA/mg protein x h), which was additive when both proteins were overexpressed together (Fig. 4A). However, no significant difference was observed in palmitoyl-CoA oxidation to ASPs in FATP1-overexpressing cells compared with LacZ control cells (27.6 +/- 0.37 nmol palmitoyl-CoA/mg protein x h; Fig. 4B).
###end p 47
###begin p 48
###xml 313 315 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 369 370 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 476 477 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 501 502 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&amp;</sup>
###xml 502 503 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Palmitoyl-CoA oxidation in mitochondrial fractions. Mitochondrial fractions that were obtained from cells infected with Ad-LacZ, Ad-FATP1, or Ad-CPT1A were incubated for 0.5 h with agitation in 400 mul of pregassed complete MKRH buffer and 50 mul of a 2.5 mM 5:1 palmitoyl-CoA-BSA complex containing 1 muCi/ml [1-14C]palmitoyl-CoA and palmitoyl-CoA, and oxidation to CO2 (A) and to ASPs (B) was measured. Data are the mean +/- SE of three experiments performed in duplicate. *P < 0.01 versus Ad-LacZ; &P < 0.01 versus the overexpression of only one protein (CPT1A or FATP1).
###end p 48
###begin p 49
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 527 533 527 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5</bold>
###xml 527 533 527 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5"><bold>Fig. 5</bold></xref>
###xml 699 705 699 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
Increased fatty acid uptake has been shown to increase transcription of CPT1 via a peroxisome proliferator-activated receptor (PPAR)-dependent pathway (28). To assess the possibility that the increase in fatty acid oxidation was due to increased expression of CPT1 in cells overexpressing FATP1 as a consequence of an increased influx of fatty acids, we performed a Western blot for CPT1 in L6E9 myotubes. CPT1 protein levels were increased in cells overexpressing CPT1 but not in those cells overexpressing FATP1 or FAT/CD36 (Fig. 5). Indeed, the overexpression of FATP1, FAT/CD36, or CPT1 only affected the expression of the protein that had been overexpressed but not the other proteins studied (Fig. 5).
###end p 49
###begin p 50
Protein expression levels of CPT1A, FATP1, and FAT/CD36 in L6E9 myotubes. Western blot for CPT1A, FATP1, and FAT/CD36 proteins was performed in 50 mug of mitochondrial fractions obtained from cells infected with Ad-LacZ, Ad-CPT1A, Ad-FATP1, and Ad-FAT/CD36. Western blot against porin was used as a mitochondrial loading control.
###end p 50
###begin title 51
Cellular localization of FATP1
###end title 51
###begin p 52
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 528 529 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 543 550 543 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 543 550 543 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6"><bold>Fig. 6A</bold></xref>
###xml 837 844 837 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6A</xref>
The increase in fatty acid oxidation in isolated mitochondria from FATP1-overexpressing cells suggested that FATP1 could be localized in the mitochondrion. Therefore, L6E9 myotubes were transfected with a plasmid that expressed an N-terminal FATP1-GFP fusion protein, and a Western blot against GFP or FATP1 was performed. We detected a band corresponding to the FATP1-GFP fusion protein (using the GFP antibody) and the endogenous FATP1 protein (using FATP1 antibody) in the 10,000 g mitochondrial pellet but not in the 10,000 g supernatant (Fig. 6A). Indeed, this distribution was similar to that of the mitochondrial marker protein porin. The same result was obtained for endogenous FAT/CD36 protein and overexpressed FAT/CD36-GFP fusion protein, which is consistent with the mitochondrial localization of FAT/CD36 protein in muscle (Fig. 6A).
###end p 52
###begin p 53
###xml 337 338 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 350 351 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 393 394 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
FATP1 localizes in mitochondria in L6E9 myotubes. A: L6E9 myoblasts were transfected with pFATP1-GFP or pFAT/CD36-GFP and induced to differentiate. Western blot analyses were performed 48 h posttransfection on total cell extracts (TE) (35 mug protein), mitochondrial enriched fractions (mit) (35 g protein) after centrifugation at 1,500 g and 10,000 g, or the supernatant (Sup.) of the 10,000 g pellet (35 mug) and membranes hybridized with antibodies against FAT/CD36, FATP1, GFP, or porin as stated. B: Colocalization analysis of the mitochondrial marker COI and FATP1-GFP. L6E9 cells were transfected with pFATP1-GFP and studied 48 h posttransfection. a: Image of the FATP1-GFP protein observed under a confocal microscope. b: Image of mitochondrial network by staining with antibodies against COI. c: Colocalization of the signal of GFP and COI. C: Qualitative analyses of colocalization were assessed using the plugin RGB Profiler from the WCIF ImageJ software. A line was drawn arbitrarily over an area of interest, and the plot presents the overlap of the intensity of each laser (from distinct labeled proteins).
###end p 53
###begin p 54
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 771 778 771 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6B</xref>
###xml 1042 1049 1042 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6C</xref>
To confirm that FATP1 is localized in mitochondria, we used immunocytochemistry in L6E9 myotubes transfected with the FATP1-GFP construct. As a marker of the mitochondrial network, we used subunit I of cytochrome c oxidase (COI), an enzyme located in the mitochondrial inner membrane that forms part of Complex IV of the respiratory chain (29). We showed that COI protein has a tubular mitochondrial pattern in L6E9 myotubes. The merging of FATP1-GFP with the mitochondrial marker COI revealed a partial overlap of these two proteins, and imaging analysis indicated a substantial colocalization of both proteins (Pearson coefficient of colocalization was 0.537, and Mander's Overlap coefficient was 0.723), confirming the mitochondrial localization of FATP1-GFP protein (Fig. 6B). Qualitative analyses of colocalization were assessed using the plugin RGB Profiler from the WCIF ImageJ software. An arbitrary line was drawn over an area of interest, and the plot presents the overlap of staining of each laser (from distinct labeled proteins; Fig. 6C).
###end p 54
###begin title 55
FAPT1 and CPT1 interact in mitochondria
###end title 55
###begin p 56
###xml 580 587 580 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 580 587 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7"><bold>Fig. 7A</bold></xref>
###xml 839 846 839 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7B</xref>
###xml 1318 1325 1318 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7C</xref>
###xml 1411 1413 1411 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 1639 1649 1639 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7A, B</xref>
###xml 1944 1951 1944 1951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7D</xref>
###xml 1388 1393 <span type="species:ncbi:9606">human</span>
###xml 1778 1781 <span type="species:ncbi:10116">rat</span>
If FATP1 is localized in mitochondria and enhances fatty acid oxidation, FATP1 and CPT1 could interact in the mitochondria. To assess this possibility, we performed coimmunoprecipitation assays. FATP1 was immunoprecipitated from total lysates of cells infected with Ad-LacZ, Ad-FAPT1, Ad-CPT1A, or Ad-FATP1 + Ad-CPT1A, and these immunoprecipitates were then subjected to a Western blot analysis using a CPT1A-specific antibody. We detected a band corresponding to CPT1 in immunoprecipitates obtained from CPT1A-overexpressing cells, showing an interaction between FATP1 and CPT1 (Fig. 7A). To confirm that the two proteins interact in mitochondria, we also performed immunoprecipitation assays using mitochondrial fractions from these cells. As shown for the case of total lysates, FATP1 and CPT1A coimmunoprecipitated in these fractions (Fig. 7B). Since we did not see coimmunoprecipitation of FATP1 and CPT1A in control LacZ cells, to rule out the possibility that the coimmunoprecipitation could be an artifact of the overexpression system, we performed immunoprecipitation assays using a greater amount of either total extracts or mitochondrial extracts. Using this approach, we showed that endogenous FATP1 and CPT1A coimmunoprecipitated in both total and mitochondria-enriched extracts in control L6E9 myotubes (Fig. 7C). FAT/CD36 has been shown to coimmunoprecipitate with CPT1 in human skeletal muscle (30). We performed immunoprecipitation assays in our system, which overexpresses FAT/CD36, and found that the two proteins also coimmunoprecipitated in both total and mitochondrial extracts when both proteins were overexpressed (Fig. 7A, B). Importantly, to confirm that FATP1 and CPT1 colocalize in mitochondria, we performed immunoprecipitation assays in vivo using rat skeletal muscle. FATP1 and CPT1 coimmunoprecipitated in both total extracts and in isolated mitochondrial fractions coming from gastrocnemius and soleus muscles (Fig. 7D).
###end p 56
###begin p 57
Coimmunoprecipitation of FATP1 and CPT1. L6E9 myotubes were transduced with Ad-LacZ, Ad-CPT1A, Ad-FATP1, and Ad-FAT/CD36, and FATP1 or FAT/CD36 proteins were immunoprecipitated using specific antibodies in either total extracts (1,000 mug) (A) or mitochondrial extracts (150 mug) (B), and CPT1A protein was detected in these immunoprecipitates by Western blot. C: FATP1 protein was immunoprecipitated in either total extracts (2,000 mug) or mitochondrial-enriched extracts (300 mug) from L6E9 myotubes, and CPT1A protein was detected by Western blot. D: FATP1 protein was immunoprecipitated in either total extracts (1,000 mug) or mitochondria-enriched extracts (150 mug) from both gastrocnemius and soleus muscles, and CPT1B protein was detected by Western blot using a specific antibody. Total expression of CPT1B in 50 mug of total and mitochondrial extracts is also shown (Input). A negative control with an unspecific antibody is also shown. IP, immunoprecipitation; IB, immunoblot.
###end p 57
###begin title 58
DISCUSSION
###end title 58
###begin p 59
###xml 186 188 186 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 1228 1232 <span type="species:ncbi:10090">mice</span>
Regulation of fatty acid oxidation in skeletal muscle has been the object of many studies attempting to explain the disconnection between malonyl-CoA levels measured in muscle and the IC50 for the muscle isoform of CPT1. In a recent study, we showed that overexpression of CPT1A in L6E9 myotubes enhanced CPT1 activity up to 15-fold, whereas fatty acid oxidation did not increase more than 2-fold, even when a mutant form of CPT1A insensitive to malonyl-CoA was overexpressed (22). These data indicate that other factors independent of the CPT1/malonyl-CoA interaction could be involved in the control of fatty acid oxidation in muscle. Furthermore, proteins other than CPT1 have recently been implicated in fatty acid import into mitochondria in muscle, such as FAT/CD36 (12) and UCP3 (31). FAT/CD36 translocates to the mitochondria during muscle contraction, increasing fatty acid oxidation. Furthermore, a null mutation in skeletal muscle FAT/CD36 reveals that palmitate metabolism is markedly downregulated under insulin- and AICAR-stimulated conditions. This indicates its critical role in fatty acid esterification and oxidation and points to another level of regulation in fatty acid oxidation (32). In these FAT/CD36 KO mice, there was an upregulation of FATP1 and FATP4 in the soleus muscle. This upregulation failed to normalize fatty acid oxidation, but it indicates that other proteins like FATP1 could collaborate in the maintenance of fatty acid metabolism. In search for a novel regulator of fatty acid metabolism in muscle, in this study, we demonstrate for the first time that FATP1, a fatty acid transport protein, is involved in mitochondrial fatty acid oxidation.
###end p 59
###begin p 60
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 870 875 <span type="species:ncbi:9606">human</span>
###xml 1059 1074 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1169 1184 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of FATP1 in L6E9 myotubes using adenovirus increased acyl-CoA synthetase activity and fatty acid incorporation into TGs, but not into other lipid species such as PL, DAG, or NEPalm. These results are consistent with other in vitro studies in 293 cells showing that fatty acids taken up by FATP1 are preferentially channeled into TG synthesis (33). Moreover, FATP1 overexpression increased fatty acid oxidation in intact myotubes. This result contrasts with the effect of FATP1 overexpression in human skeletal muscle cells, where palmitate incorporation into TG, but not fatty acid oxidation, was also increased (18). This discrepancy could be due to differences in the model studied and the method used: in this study, palmitate oxidation was measured in the presence of 2.5 mM glucose, whereas in the previous study, palmitate oxidation was measured in human skeletal muscle cells and in the absence of glucose. The increase in fatty acid oxidation in FATP1-overexpressing L6E9 myotubes in our study is consistent with the increase shown for transgenic mice overexpressing FATP1 in heart (17). However, the TG levels were not increased in the heart of transgenic mice.
###end p 60
###begin p 61
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 927 929 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
To assess whether the increase in fatty acid oxidation is a result of an increase in fatty acid uptake at the plasma membrane or due to a mitochondrial role of FATP1, we isolated mitochondrial-enriched fractions and measured palmitate oxidation. We found that FATP1 overexpression increased mitochondrial fatty acid oxidation, as did the overexpression of CPT1A, the endogenous CPT1 isoform expressed in these cells (22). Importantly, the overexpression of both proteins together produced an additive effect, indicating that FATP1 and CPT1 collaborate in these cells for mitochondrial fatty acid oxidation. It has been suggested than when the rate of mitochondrial beta-oxidation is increased and exceeds flux through the tricarboxylic acid cycle and electron transport chain, incomplete fatty acid oxidation occurs, leading to intramitochondrial metabolite accumulation, mitochondrial stress, and cellular insulin resistance (34). In our study, FATP1 overexpression produced a higher increase in complete than in incomplete fatty acid oxidation, indicating that the effect of this protein on fatty acid oxidation does not involve the accumulation of intermediary species of fatty acid oxidation. Hence, FATP1 overexpression increased the efficiency of the mitochondria to oxidize fatty acids, as indicated by the diminished ratio incomplete/complete fatty acid oxidation. This effect was also seen in cells overexpressing CPT1A, especially when both FATP1 and CPT1A were cooverexpressed, showing a higher coupling of mitochondrial fatty acid uptake and oxidation. Interestingly, the use of etomoxir showed that the control of mitochondrial fatty acid uptake was dominated by CPT1, and the overexpression of FATP1 had no effect when CPT1 was inhibited. This indicates that FATP1 contributes to fatty acid oxidation by collaborating with CPT1, but not by controlling the entry of fatty acids to the mitochondria.
###end p 61
###begin p 62
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 1217 1219 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 1596 1598 1596 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 1726 1728 1726 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 1860 1862 1860 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 1432 1437 <span type="species:ncbi:9606">human</span>
###xml 1696 1701 <span type="species:ncbi:9606">human</span>
If FATP1 has a role in mitochondrial fatty acid oxidation, it might be localized in mitochondria. To examine this possibility, we used different techniques. Western blot analysis demonstrated that the protein was present in mitochondrial fractions but not in cytosolic fractions. Moreover, using immunocytochemistry, we showed both qualitatively and quantitatively that FATP1-GFP protein localized partially in structures that were also positive for the mitochondrial protein COI, indicating that FATP1 is partially localized in mitochondria in L6E9 myotubes. We used GFP fluorescence since the FATP1 antibodies were unsuitable for immunocytochemistry studies. Although the fusion with GFP could affect the localization of the protein, we do not believe this is the case. In the Western blot experiments, the FATP1-GFP and the endogenous protein showed the same distribution pattern of localization after the cellular fractionation, and another report (35) showed that the N-terminal GFP-tagged FATP1 protein retained the ability to bind to membranes. In our study, not all the FATP1 colocalized with the mitochondrial marker COI. It has been described that FATP1 can also localize in the endoplasmic reticulum (ER) (35). Given the reticular pattern of GFP fluorescence that we observed in L6E9 cells, we cannot rule out the possibility that a portion of FATP1-GFP could also localize in the ER. Furthermore, in a previous study in human myotubes, overexpressed FATP1-GFP also showed a cytosolic reticular pattern, but colocalization studies with a mitochondrial or ER marker were not performed (18). Moreover, recent data from our group demonstrated that FATP1 also localizes in mitochondria in human and C2C12 muscle cells (36), and in adipocytes, 70% of FATP1 localizes in cell membrane fraction and approximately 10% in the nuclear-mitochondrial fraction (16).
###end p 62
###begin p 63
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 399 402 <span type="species:ncbi:10116">rat</span>
###xml 931 934 <span type="species:ncbi:10116">rat</span>
###xml 1084 1087 <span type="species:ncbi:10116">rat</span>
The additive effect of FATP1 and CPT1 overexpression in fatty acid oxidation and the mitochondrial localization of both proteins indicate that these two proteins may interact in the mitochondrion. We show that both proteins coimmunoprecipitated both in total extracts and in mitochondrial extracts, strongly supporting the hypothesis that FATP1 and CPT1 interact in mitochondria. Importantly, using rat skeletal muscle, we also showed that FATP1 and CPT1 coimmunoprecipitated both in total extracts and in mitochondria-enriched fractions, indicating that the interaction between FATP1 and CPT1 also occurs in skeletal muscle in vivo. Moreover, this coimmunoprecipitation was higher in soleus than in gastrocnemius muscle. This indicates that in oxidative muscle, which uses primary fatty acids as an energy source, the interaction between FATP1 and CPT1 could be higher than in glycolytic muscles. Furthermore, FATP1 expression in rat oxidative muscle (soleus) is approximately twice that in glycolytic (gastrocnemius) muscle (37). Our immunoprecipitation assays in L6E9 myotubes and rat skeletal muscle show that FATP1 and CPT1 interact in basal conditions, suggesting that FATP1 could be constitutively present in mitochondria. However, some hormonal or physiological factors that induce fatty acid oxidation, such as exercise, could also induce the presence of FATP1 in mitochondria. Future studies are needed to examine this possibility.
###end p 63
###begin p 64
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 872 873 872 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
FATP1 is an integral membrane protein with at least one transmembrane and multiple membrane-associated domains (35). It contains an AMP-binding motif that is essential for transport function (38). FATP1 has acyl-CoA synthetase activity, suggesting that fatty acid uptake catalyzed by FATP1 is linked to the esterification of these fatty acids with CoA (13). Moreover, FATP1 was shown to heterooligomerize with the LCFA-CoA syntethase ACSL1 in differentiated 3T3-L1 adipocytes (39). Given all the above observations, it could be hypothesized that FATP1 could act as a long-chain acyl-CoA synthetase in mitochondria to activate LCFAs, which CPT1 can then use as a substrate. However, interestingly, although acyl-CoA synthetase activity is increased in mitochondrial fractions from FATP1-overexpressing L6E9 myotubes, we show that mitochondrial palmitoyl-CoA oxidation to CO2 is also increased in these fractions, as is the oxidation of palmitate, suggesting a role for FATP1 in mitochondrial fatty acid oxidation independent of its acyl-CoA synthetase activity.
###end p 64
###begin p 65
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 1461 1463 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 1593 1595 1593 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 2088 2090 2088 2090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 969 984 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1441 1445 <span type="species:ncbi:10116">rats</span>
###xml 1453 1459 <span type="species:ncbi:9606">humans</span>
In this study, we have also analyzed the effect of overexpression of FAT/CD36 in L6E9 myotubes. This has been described as a new protein involved in mitochondrial fatty acid oxidation under stimulated conditions (12). Thus, the presence of FAT/CD36 in mitochondria is induced by exercise or contraction (12). However, FAT/CD36 KO mice have normal basal mitochondrial fatty acid oxidation despite the absence of FAT/CD36 protein (40). These results suggest that FAT/CD36 could have a role in mitochondrial fatty acid oxidation only under certain conditions of increased requirements for fatty acid oxidation, such as during exercise or muscle contraction. Moreover, FAT/CD36 has been shown to translocate from intracellular vesicles to the plasma membrane in response to insulin (41). In this study, we have demonstrated that overexpression of FAT/CD36 enhances fatty acid oxidation, in agreement with the increase in fatty acid oxidation shown in contracting muscle in transgenic mice overexpressing FAT/CD36 (42). Furthermore, FAT/CD36 coimmunoprecipitated with CPT1 in L6E9 myotubes, and its overexpression increased mitochondrial fatty acid oxidation and mitochondrial fatty acid oxidation efficiency, showing an additive effect when cooverexpressed with CPT1. It has already been shown that FAT/CD36 translocates to the mitochondrial membrane in response to exercise, increasing the ability of mitochondria to oxidize palmitate, both in rats and in humans (12, 43). Moreover, FAT/CD36 coimmunoprecipitates with CPT1, and this correlates with the level of fat oxidation in skeletal muscle (30). Thus, our results in L6E9 myotubes are in agreement with these previous data and validate our model of study. Therefore, according to our data, FATP1 enhances fatty acid oxidation similar to FAT/CD36, suggesting that such effect may be due to fatty acid recruitment at mitochondria by either fatty acid binding protein. However, in a recent study, we have shown that FATP1, unlike FAT/CD36, stimulates the pyruvate dehydrogenase complex activity and glucose oxidation in cultured myotubes (36), indicating that FATP1 exerts differential effects on mitochondrial metabolism.
###end p 65
###begin p 66
In summary, we demonstrate for the first time that FATP1 has a role in mitochondrial fatty acid oxidation in collaboration with CPT1. The exact mechanism of this interaction and its regulation remain to be resolved. However, the data presented here reveal a new protein involved in mitochondrial oxidation of fatty acids and could help us to understand the complex regulation of fatty acid oxidation in skeletal muscle.
###end p 66
###begin p 67
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 90 93 <span type="species:ncbi:10116">rat</span>
###xml 138 141 <span type="species:ncbi:10116">rat</span>
We thank Dr. Prip-Buus and Dr. Zammit for supplying anti-rat liver CPT1 antibody and anti-rat muscle CPT1 antibody respectively. The L6E9 rat skeletal muscle cell line was kindly provided by Dr. A. Zorzano (University of Barcelona). We are also grateful to Robin Rycroft of the Language Service for valuable assistance in the preparation of the manuscript.
###end p 67
###begin title 68
REFERENCES
###end title 68
###begin article-title 69
Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. 
###end article-title 69
###begin article-title 70
The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. 
###end article-title 70
###begin article-title 71
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. 
###end article-title 71
###begin article-title 72
###xml 76 79 <span type="species:ncbi:10116">rat</span>
High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: isolation and characterization of its cDNA clone. 
###end article-title 72
###begin article-title 73
A novel brain-expressed protein related to carnitine palmitoyltransferase I. 
###end article-title 73
###begin article-title 74
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. 
###end article-title 74
###begin article-title 75
###xml 99 102 <span type="species:ncbi:9606">men</span>
Effects of increased fat availability on fat-carbohydrate interaction during prolonged exercise in men. 
###end article-title 75
###begin article-title 76
###xml 62 67 <span type="species:ncbi:9606">human</span>
Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. 
###end article-title 76
###begin article-title 77
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. 
###end article-title 77
###begin article-title 78
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 213 216 <span type="species:ncbi:10116">rat</span>
Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. 
###end article-title 78
###begin article-title 79
Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. 
###end article-title 79
###begin article-title 80
A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. 
###end article-title 80
###begin article-title 81
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. 
###end article-title 81
###begin article-title 82
A current review of fatty acid transport proteins (SLC27). 
###end article-title 82
###begin article-title 83
###xml 47 52 <span type="species:ncbi:9606">human</span>
Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. 
###end article-title 83
###begin article-title 84
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. 
###end article-title 84
###begin article-title 85
Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. 
###end article-title 85
###begin article-title 86
###xml 115 120 <span type="species:ncbi:9606">human</span>
Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. 
###end article-title 86
###begin article-title 87
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. 
###end article-title 87
###begin article-title 88
Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. 
###end article-title 88
###begin article-title 89
FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. 
###end article-title 89
###begin article-title 90
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance. 
###end article-title 90
###begin article-title 91
Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase I in INS1E cells: effects on cell metabolism and insulin secretion. 
###end article-title 91
###begin article-title 92
14CO2 production is no adequate measure of [14C]fatty acid oxidation. 
###end article-title 92
###begin article-title 93
###xml 99 123 99 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 43 46 <span type="species:ncbi:10116">rat</span>
###xml 99 123 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Topological and functional analysis of the rat liver carnitine palmitoyltransferase 1 expressed in Saccharomyces cerevisiae. 
###end article-title 93
###begin article-title 94
Structural and functional genomics of the CPT1B gene for muscle-type carnitine palmitoyltransferase I in mammals. 
###end article-title 94
###begin article-title 95
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Biochemical and functional differences in rat liver mitochondrial subpopulations obtained at different gravitational forces. 
###end article-title 95
###begin article-title 96
###xml 11 16 <span type="species:ncbi:9606">human</span>
Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. 
###end article-title 96
###begin article-title 97
The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. 
###end article-title 97
###begin article-title 98
Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training. 
###end article-title 98
###begin article-title 99
The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity?
###end article-title 99
###begin article-title 100
A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. 
###end article-title 100
###begin article-title 101
FATP1 channels exogenous FA into 1,2,3-triacyl-sn-glycerol and down-regulates sphingomyelin and cholesterol metabolism in growing 293 cells. 
###end article-title 101
###begin article-title 102
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. 
###end article-title 102
###begin article-title 103
###xml 25 31 <span type="species:ncbi:10090">murine</span>
Membrane topology of the murine fatty acid transport protein 1. 
###end article-title 103
###begin article-title 104
FATP1 localizes to mitochondria and enhances pyruvate dehydrogenase activity in skeletal myotubes. 
###end article-title 104
###begin article-title 105
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Fiber type- and fatty acid composition-dependent effects of high-fat diets on rat muscle triacylglyceride and fatty acid transporter protein-1 content. 
###end article-title 105
###begin article-title 106
###xml 46 52 <span type="species:ncbi:10090">murine</span>
Substitution of alanine for serine 250 in the murine fatty acid transport protein inhibits long chain fatty acid transport. 
###end article-title 106
###begin article-title 107
Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes. 
###end article-title 107
###begin article-title 108
Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36. 
###end article-title 108
###begin article-title 109
Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane. 
###end article-title 109
###begin article-title 110
Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. 
###end article-title 110
###begin article-title 111
###xml 44 49 <span type="species:ncbi:9606">human</span>
Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation. 
###end article-title 111
###begin p 112
###xml 0 14 0 14 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="113">Abbreviations:</title>
###xml 14 17 14 17 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ASP</term>
###xml 17 37 17 37 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="114">acid-soluble product</p>
###xml 17 37 17 37 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="114">acid-soluble product</p></def>
###xml 14 37 14 37 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>ASP</term><def><p textid="114">acid-soluble product</p></def></def-item>
###xml 37 40 37 40 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COI</term>
###xml 40 73 40 73 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="115">subunit I of cytochrome c oxidase</p>
###xml 40 73 40 73 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="115">subunit I of cytochrome c oxidase</p></def>
###xml 37 73 37 73 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>COI</term><def><p textid="115">subunit I of cytochrome c oxidase</p></def></def-item>
###xml 73 77 73 77 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CPT1</term>
###xml 77 109 77 109 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="116">carnitine palmitoyltransferase 1</p>
###xml 77 109 77 109 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="116">carnitine palmitoyltransferase 1</p></def>
###xml 73 109 73 109 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>CPT1</term><def><p textid="116">carnitine palmitoyltransferase 1</p></def></def-item>
###xml 109 112 109 112 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DAG</term>
###xml 112 126 112 126 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="117">diacylglycerol</p>
###xml 112 126 112 126 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="117">diacylglycerol</p></def>
###xml 109 126 109 126 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>DAG</term><def><p textid="117">diacylglycerol</p></def></def-item>
###xml 126 128 126 128 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ER</term>
###xml 128 149 128 149 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="118">endoplasmic reticulum</p>
###xml 128 149 128 149 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="118">endoplasmic reticulum</p></def>
###xml 126 149 126 149 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>ER</term><def><p textid="118">endoplasmic reticulum</p></def></def-item>
###xml 149 154 149 154 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FATP1</term>
###xml 154 184 154 184 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="119">fatty acid transport protein 1</p>
###xml 154 184 154 184 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="119">fatty acid transport protein 1</p></def>
###xml 149 184 149 184 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>FATP1</term><def><p textid="119">fatty acid transport protein 1</p></def></def-item>
###xml 184 192 184 192 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FAT/CD36</term>
###xml 192 219 192 219 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="120">fatty acid translocase/CD36</p>
###xml 192 219 192 219 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="120">fatty acid translocase/CD36</p></def>
###xml 184 219 184 219 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>FAT/CD36</term><def><p textid="120">fatty acid translocase/CD36</p></def></def-item>
###xml 219 222 219 222 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</term>
###xml 222 247 222 247 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="121">green fluorescent protein</p>
###xml 222 247 222 247 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="121">green fluorescent protein</p></def>
###xml 219 247 219 247 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>GFP</term><def><p textid="121">green fluorescent protein</p></def></def-item>
###xml 247 251 247 251 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KRBH</term>
###xml 251 288 251 288 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="122">Krebs-Ringer bicarbonate HEPES buffer</p>
###xml 251 288 251 288 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="122">Krebs-Ringer bicarbonate HEPES buffer</p></def>
###xml 247 288 247 288 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>KRBH</term><def><p textid="122">Krebs-Ringer bicarbonate HEPES buffer</p></def></def-item>
###xml 288 292 288 292 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LCFA</term>
###xml 292 313 292 313 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="123">long-chain fatty acid</p>
###xml 292 313 292 313 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="123">long-chain fatty acid</p></def>
###xml 288 313 288 313 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>LCFA</term><def><p textid="123">long-chain fatty acid</p></def></def-item>
###xml 313 317 313 317 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MKRH</term>
###xml 317 344 317 344 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="124">modified Krebs Ringer HEPES</p>
###xml 317 344 317 344 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="124">modified Krebs Ringer HEPES</p></def>
###xml 313 344 313 344 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>MKRH</term><def><p textid="124">modified Krebs Ringer HEPES</p></def></def-item>
###xml 344 350 344 350 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NEPalm</term>
###xml 350 373 350 373 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="125">nonesterified palmitate</p>
###xml 350 373 350 373 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="125">nonesterified palmitate</p></def>
###xml 344 373 344 373 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>NEPalm</term><def><p textid="125">nonesterified palmitate</p></def></def-item>
###xml 373 375 373 375 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PL</term>
###xml 375 387 375 387 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="126">phospholipid</p>
###xml 375 387 375 387 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="126">phospholipid</p></def>
###xml 373 387 373 387 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PL</term><def><p textid="126">phospholipid</p></def></def-item>
###xml 387 391 387 391 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPAR</term>
###xml 391 433 391 433 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="127">peroxisome proliferator-activated receptor</p>
###xml 391 433 391 433 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="127">peroxisome proliferator-activated receptor</p></def>
###xml 387 433 387 433 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PPAR</term><def><p textid="127">peroxisome proliferator-activated receptor</p></def></def-item>
###xml 433 435 433 435 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TG</term>
###xml 435 451 435 451 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="128">triacylglyceride</p>
###xml 435 451 435 451 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="128">triacylglyceride</p></def>
###xml 433 451 433 451 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>TG</term><def><p textid="128">triacylglyceride</p></def></def-item>
###xml 0 451 0 451 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="113">Abbreviations:</title><def-item><term>ASP</term><def><p textid="114">acid-soluble product</p></def></def-item><def-item><term>COI</term><def><p textid="115">subunit I of cytochrome c oxidase</p></def></def-item><def-item><term>CPT1</term><def><p textid="116">carnitine palmitoyltransferase 1</p></def></def-item><def-item><term>DAG</term><def><p textid="117">diacylglycerol</p></def></def-item><def-item><term>ER</term><def><p textid="118">endoplasmic reticulum</p></def></def-item><def-item><term>FATP1</term><def><p textid="119">fatty acid transport protein 1</p></def></def-item><def-item><term>FAT/CD36</term><def><p textid="120">fatty acid translocase/CD36</p></def></def-item><def-item><term>GFP</term><def><p textid="121">green fluorescent protein</p></def></def-item><def-item><term>KRBH</term><def><p textid="122">Krebs-Ringer bicarbonate HEPES buffer</p></def></def-item><def-item><term>LCFA</term><def><p textid="123">long-chain fatty acid</p></def></def-item><def-item><term>MKRH</term><def><p textid="124">modified Krebs Ringer HEPES</p></def></def-item><def-item><term>NEPalm</term><def><p textid="125">nonesterified palmitate</p></def></def-item><def-item><term>PL</term><def><p textid="126">phospholipid</p></def></def-item><def-item><term>PPAR</term><def><p textid="127">peroxisome proliferator-activated receptor</p></def></def-item><def-item><term>TG</term><def><p textid="128">triacylglyceride</p></def></def-item></def-list>
Abbreviations:ASPacid-soluble productCOIsubunit I of cytochrome c oxidaseCPT1carnitine palmitoyltransferase 1DAGdiacylglycerolERendoplasmic reticulumFATP1fatty acid transport protein 1FAT/CD36fatty acid translocase/CD36GFPgreen fluorescent proteinKRBHKrebs-Ringer bicarbonate HEPES bufferLCFAlong-chain fatty acidMKRHmodified Krebs Ringer HEPESNEPalmnonesterified palmitatePLphospholipidPPARperoxisome proliferator-activated receptorTGtriacylglyceride
###end p 112
###begin title 113
Abbreviations:
###end title 113
###begin p 114
acid-soluble product
###end p 114
###begin p 115
subunit I of cytochrome c oxidase
###end p 115
###begin p 116
carnitine palmitoyltransferase 1
###end p 116
###begin p 117
diacylglycerol
###end p 117
###begin p 118
endoplasmic reticulum
###end p 118
###begin p 119
fatty acid transport protein 1
###end p 119
###begin p 120
fatty acid translocase/CD36
###end p 120
###begin p 121
green fluorescent protein
###end p 121
###begin p 122
Krebs-Ringer bicarbonate HEPES buffer
###end p 122
###begin p 123
long-chain fatty acid
###end p 123
###begin p 124
modified Krebs Ringer HEPES
###end p 124
###begin p 125
nonesterified palmitate
###end p 125
###begin p 126
phospholipid
###end p 126
###begin p 127
peroxisome proliferator-activated receptor
###end p 127
###begin p 128
triacylglyceride
###end p 128
###begin p 129
This study was supported by Grant SAF2007-61926 from the Ministerio de Educacion y Ciencia; by Grant C3/08 from the Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III; by the Ajut de Suport als Grups de Recerca de Catalunya (2005SGR-00733), Spain (to F.G.H.), and by Grants SAF2006-07228 from the Ministerio de Ciencia y Tecnologia and REDIMET RD06/0015/0018 (to A.M.G-F.). CIBER Fisiopatologia de la Obesidad y Nutricion and CIBER Diabetes y Enfermedades Metabolicas Asociadas are an initiative of Instituto de Salud Carlos III.
###end p 129

